Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies

Background: Spatial and temporal heterogeneities of RAS and other molecular genes should be considered in the treatment of metastatic colorectal cancer (mCRC) treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs); acquired RAS mutation is sometimes observed at diseas...

Полное описание

Библиографические подробности

Главные авторы:	Kozo Kataoka, Takeshi Yamada, Manabu Shiozawa, Naoto Takase, Kazuma Ito, Kentaro Yamazaki, Jun Watanabe, Toshihiro Kudo, Takeshi Suto, Toshihiko Matsumoto, Kohei Murata, Yusuke Suwa, Shogen Boku, Hisateru Yasui, Nobuhisa Matsuhashi, Atsuyuki Maeda, Kiichi Sugimoto, Yusuke Matsumoto, Mitsuru Yokota, Johannes Fredebohm, Keita Mori, Masataka Ikeda
Формат:	Artigo
Язык:	Inglês
Опубликовано:	The Japan Society of Coloproctology 2024-04-01
Серии:	Journal of the Anus, Rectum and Colon
Предметы:	colorectal cancer anti-egfr monoclonal antibody ras-trace ras-trace-2 ctdna
Online-ссылка:	https://www.jstage.jst.go.jp/article/jarc/8/2/8_2023-051/_pdf/-char/en
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!